Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.002 Å; R factor = 0.041; wR factor = 0.102; data-to-parameter ratio = 11.6. organic compounds o2476 Santos et al.
In the title compound, C 18 H 16 N 4 O 2 , the plane defined by the ethyl C atoms and the attached N atom is inclined to the adjacent pyridine ring at an angle of 67.87 (16) . The dihedral angle between the two heterocyclic rings is 3.33 (16) . The molecular conformation is stabilized by an intramolecular N-HÁ Á ÁO hydrogen bond and the crystal structure by intermolecular C-HÁ Á ÁO hydrogen bonds, forming a one-dimensional structure.
Related literature
For the biological properties of oxoquinoline derivatives, see: Van Bambeke et al. (2005) ; Canuto et al. (2007) ; Lucero et al. (2006) . For their potential use in the treatment of fungal and viral infections, see: Brideau et al. (2002) ; Souza et al. (2008) and in cancer chemotherapy, see: Chu et al. (1992) . For acylhydrazones and their antileishmanial activity, see: Bernadino et al. (2006) ; Cunha et al. (2003) . For bond-length data, see: Allen et al. (1987) Table 1 Hydrogen-bond geometry (Å , ).
Data collection: COLLECT (Nonius, 2000) ; cell refinement: HKL SCALEPACK (Otwinowski & Minor 1997) ; data reduction: HKL DENZO (Otwinowski & Minor 1997) and SCALEPACK; program(s) used to solve structure: SIR2002 (Burla et al., 2003) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 (Farrugia, 1997) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: WinGX publication routines (Farrugia, 1999) . Since the discovery of nalidixic acid, the parent compound of the 1,4-dihydro-4-oxoquinoline antibiotics, the molecular structures of oxoquinolines have been extensively modified to improve their pharmacological properties and pharmacokinetic profiles (Van Bambeke et al., 2005) . 1,4-Dihydro-4-oxoquinolines have a broad antimicrobial spectrum, are orally and parenterally active and, apart from a few exceptions, are non-toxic compounds. Therefore, they are important agents against microbial pathogens. They have also been considered for the treatment of fungal and viral (Brideau et al., 2002; Souza et al., 2008) infections and for cancer chemotherapy (Chu et al., 1992) . Our research group has designed and synthesized new oxoquinoline derivatives, such as ribonucleosides (Canuto et al., 2007) and acyclonucleosides (Lucero et al., 2006) . These compounds exhibited interesting activity against HIV-1 and HSV viruses, respectively.
Continuing our interest in the chemistry of oxoquinolinic molecules, we decided to prepare a congener series of new acylhydrazones (Cunha et al., 2003) and test them for antileishmanial activity. These studies showed that the hydrazone group plays an important role in antileishmanial activity (Bernadino et al., 2006) . Among these compounds, (E)-1-ethyl-N'-[(pyrid-4'-yl)methylene]-1,4-dihydro-4-oxoquinoline-3-carbohydrazide, was found to exhibit a significant activity against Leishmania amazonensis.
As an extension of our work on the structural characterization of oxoquinolinic derivatives (Canuto et al., 2007; Lucero et al. 2006) . the crystal structure of the title compound is reported here. In the title compound ( Fig. 1) , the dihedral angle between the C1,C6-C9/N1 ring and the C14-C18/N4 pyridine ring is 3.33 (16)°. The plane defined by N1,C10,C11 is inclined to the C1,C6-C9/N1 ring at an angle of 67.87 (16)°. The torsion angles C8-C12-N3-N2, C12-N3-N2-C13 and N3-N2-C13-C14 are 0.79 (14), 1.38 (16) and 1.53 (14)°, respectively. All the bond lengths are within normal ranges (Allen et al., 1987) . The molecular structure is stabilized by an intramolecular N-H···O hydrogen bond (Table 1) . The crystal structure is stabilized by intermolecular C-H···O hydrogen bonds, forming a one-dimensional structure (Table 1 and Fig. 2 ).
Experimental
A solution of 1-ethyl-1,4-dihydro-4-oxoquinoline ethyl carboxylate (3.70 mmol) and 3.7 ml of 80% hydrazine monohydrate in 10 ml of dimethylformamide was stirred under reflux for two hours. The reaction mixture was poured into ice, giving rise to a white solid that was collected by filtration, washed with cold ethyl acetate and dried under vacuum, leading to the pure desired 1-ethyl-1,4-dihydro-4-oxoquinoline-3-carbohydrazide, in 90% yield. This carbohydrazide (1.00 mmol) and pyridine-4-carbaldehyde (1.10 mmol) in 5 ml of dimethylformamide and a catalytic amount of 35% HCl were stirred at room temperature. The reaction mixture was poured into ice, leading to a white solid that was collected by filtration, giving (E)-1-ethyl-N'-[(pyrid-4'-yl)methylene]-1,4-dihydro-4-oxoquinoline-3-carbohydrazide in 83% yield after purification. supplementary materials sup-2
Refinement
The N-bound H atom was located in a difference map and refined freely [to N-H = 0.92 (2) Å]. The other H atoms were positioned with idealized geometry and refined using a riding model, with C-H = 0.93 Å for aryl, 0.97 Å for methylene, and 0.96 Å for methyl H atoms. The constraints U iso (H) = 1.2U eq (C) and 1.5U eq (C) (methyl C) were applied. Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) 0.0360 (9) 0.0428 (10) 0.0343 (9) 0.0027 (7) 0.0088 (7) −0.0018 (7) C7 0.0364 (9) 0.0365 (9) 0.0388 (9) 0.0030 (7) 0.0075 (7) −0.0011 (7) C8 0.0391 (9) 0.0362 (9) 0.0354 (9) 0.0013 (7) 0.0101 (7) −0.0018 (7) C9 0.0456 (10) 0.0427 (10) 0.0342 (9) −0.0017 (8) 0.0132 (7) −0.0055 (7) 0.0520 (10) 0.0398 (10) 0.0368 (9) −0.0028 (8) 0.0071 (8) −0.0011 (7) C14 0.0380 (9) 0.0378 (9) 0.0394 (9) 0.0020 (7) 0.0029 (7) 0.0047 (7) C15 0.0611 (12) 0.0424 (10) 0.0440 (10) −0.0037 (9) 0.0066 (9) 0.0000 (8) 
